Recursion Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Recursion Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker RXRX.
Recursion Pharmaceuticals, Inc. operates as a biotechnology firm currently in its clinical development phase. The company's mission is to revolutionize drug discovery by decoding biological processes, utilizing an integrated approach that combines technological innovations across biology, chemistry, automation, data science, and engineering. Their developmental pipeline features several clinical-stage compounds:...
Can you invest in Recursion Pharmaceuticals, Inc.?
Yes. Recursion Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker RXRX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Recursion Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.